Proteomic applications in blood transfusion: Working the jigsaw puzzle

Vox Sanguinis

Volumn 100, Issue 1, 2011, Pages 84-91

  Devine, D V ^a   Schubert, P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Blood components; Blood plasma; Blood platelets; Proteomics; Red blood cells; Transfusion medicine

Indexed keywords

PLASMA PROTEIN;

BLOOD STORAGE; BLOOD TRANSFUSION; ERYTHROCYTE; MASS SPECTROMETRY; PLASMA; PRIORITY JOURNAL; PROTEOMICS; QUALITY CONTROL; REVIEW; SICKLE CELL ANEMIA; THROMBOCYTE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BLOOD PLATELETS; BLOOD PROTEINS; BLOOD SAFETY; BLOOD TRANSFUSION; ERYTHROCYTES; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MASS SPECTROMETRY; PROTEOMICS;

EID: 78650358390     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2010.01433.x     Document Type: Review

References (72)

1. Anderson NL, Anderson NG: Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis 1998; 19:1853-1861
2. Blackstock WP, Weir MP: Proteomics: quantitative and physical mapping of cellular proteins. Trends Biotechnol 1999; 17:121-127
3. Wilkins MR, Pasquali C, Appel RD, et al. From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis. Biotechnology (N Y) 1996; 14:61-65
4. James P: Protein identification in the post-genome era: the rapid rise of proteomics. Q Rev Biophys 1997; 30:279-331
5. Choudhary C, Mann M: Decoding signalling networks by mass spectrometry-based proteomics. Nat Rev Mol Cell Biol 2010; 11:427-439
6. Walther TC, Mann M: Mass spectrometry-based proteomics in cell biology. J Cell Biol 2010; 190:491-500
7. Findeisen P, Neumaier M: Mass spectrometry-based clinical proteomics profiling: current status and future directions. Expert Rev Proteomics 2009; 6:457-459
8. Aebersold R, Mann M: Mass spectrometry-based proteomics. Nature 2003; 422:198-207
9. Corthals GL, Wasinger VC, Hochstrasser DF, et al. The dynamic range of protein expression: a challenge for proteomic research. Electrophoresis 2000; 21:1104-1115
10. Zhao Y, Jensen ON: Modification-specific proteomics: strategies for characterization of post-translational modifications using enrichment techniques. Proteomics 2009; 9:4632-4641
11. Anderson L, Anderson NG: High resolution two-dimensional electrophoresis of human plasma proteins. Proc Natl Acad Sci USA 1977; 74:5421-5425
12. Pearson TW, Anderson NL: Use of high-resolution two-dimensional gel electrophoresis for analysis of monoclonal antibodies and their specific antigens. Methods Enzymol 1983; 92:196-220
13. Bandow JE: Comparison of protein enrichment strategies for proteome analysis of plasma. Proteomics 2010; 10:1416-1425
14. Frank R, Hargreaves R: Clinical biomarkers in drug discovery and development. Nat Rev Drug Discov 2003; 2:566-580
15. Schenk S, Schoenhals GJ, de Souza G, et al. A high confidence, manually validated human blood plasma protein reference set. BMC Med Genomics 2008; 1:41
16. Brigulla M, Thiele T, Scharf C, et al. Proteomics as a tool for assessment of therapeutics in transfusion medicine: evaluation of prothrombin complex concentrates. Transfusion 2006; 46:377-385
17. Clifton JG, Huang F, Kovac S, et al. Proteomic characterization of plasma-derived clotting factor VIII-von Willebrand factor concentrates. Electrophoresis 2009; 30:3636-3646
18. Clifton J, Huang F, Gaso-Sokac D, et al. Use of proteomics for validation of the isolation process of clotting factor IX from human plasma. J Proteomics 2010; 73:678-688
19. Steil L, Thiele T, Hammer E, et al. Proteomic characterization of freeze-dried human plasma: providing treatment of bleeding disorders without the need for a cold chain. Transfusion 2008; 48:2356-2363
20. Sidhu RS, Le T, Brimhall B, et al. Study of coagulation factor activities in apheresed thawed fresh frozen plasma at 1-6 degrees C for five days. J Clin Apher 2006; 21:224-226
21. von Heymann C, Keller MK, Spies C, et al. Activity of clotting factors in fresh-frozen plasma during storage at 4 degrees C over 6-days. Transfusion 2009; 49:913-920
22. Yazer MH, Cortese-Hassett A, Triulzi DJ: Coagulation factor levels in plasma frozen within 24-hours of phlebotomy over 5-days of storage at 1 to 6 degrees C. Transfusion 2008; 48:2525-2530
23. Crettaz D, Sensebe L, Vu DH, et al. Proteomics of methylene blue photo-treated plasma before and after removal of the dye by an absorbent filter. Proteomics 2004; 4:881-891
24. Anniss AM, Glenister KM, Killian JJ, et al. Proteomic analysis of supernatants of stored red blood cell products. Transfusion 2005; 45:1426-1433
25. Bosman GJ, Lasonder E, Groenen-Dopp YA, et al. Comparative proteomics of erythrocyte aging in vivo and in vitro. J Proteomics 2010; 73:396-402
26. Bosman GJ, Lasonder E, Luten M, et al. The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion 2008; 48:827-835
27. D'Amici GM, Rinalducci S, Zolla L: Proteomic analysis of RBC membrane protein degradation during blood storage. J Proteome Res 2007; 6:3242-3255
28. Rubin O, Crettaz D, Canellini G, et al. Microparticles in stored red blood cells: an approach using flow cytometry and proteomic tools. Vox Sang 2008; 95:288-297
29. Bosman GJ, Stappers M, Novotny VM: Changes in band 3 structure as determinants of erythrocyte integrity during storage and survival after transfusion. Blood Transfus 2010; 8(Suppl 3):s48-s52
30. Thiele T, Steil L, Gebhard S, et al. Profiling of alterations in platelet proteins during storage of platelet concentrates. Transfusion 2007; 47:1221-1233
31. Schubert P, Devine DV: De novo protein synthesis in mature platelets: a consideration for transfusion medicine. Vox Sang 2010; 99:112-122
32. Mohr H, Steil L, Gravemann U, et al. A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light. Transfusion 2009; 49:2612-2624
33. Schwertz H, Koster S, Kahr WH, et al. Anucleate platelets generate progeny. Blood 2010; 115:3801-3809
34. Peter K: Proteomics unravels platelet function. Blood 2010; 115:4008-4009
35. Schulz C, Leuschen NV, Frohlich T, et al. Identification of novel downstream targets of platelet glycoprotein VI activation by differential proteome analysis: implications for thrombus formation. Blood 2010; 115:4102-4110
36. Baker ES, Livesay EA, Orton DJ, et al. An LC-IMS-MS platform providing increased dynamic range for high-throughput proteomic studies. J Proteome Res 2010; 9:997-1006
37. Greening DW, Simpson RJ: A centrifugal ultrafiltration strategy for isolating the low-molecular weight (
38. Hu L, Ye M, Zou H: Recent advances in mass spectrometry-based peptidome analysis. Expert Rev Proteomics 2009; 6:433-447
39. Mauri P, Scigelova M: Multidimensional protein identification technology for clinical proteomic analysis. Clin Chem Lab Med 2009; 47:636-646
40. Callesen AK, Madsen JS, Vach W, et al. Serum protein profiling by solid phase extraction and mass spectrometry: a future diagnostics tool? Proteomics 2009; 9:1428-1441
41. Nissum M, Foucher AL: Analysis of human plasma proteins: a focus on sample collection and separation using free-flow electrophoresis. Expert Rev Proteomics 2008; 5:571-587
42. Barelli S, Crettaz D, Thadikkaran L, et al. Plasma/serum proteomics: pre-analytical issues. Expert Rev Proteomics 2007; 4:363-370
43. Omenn GS, States DJ, Adamski M, et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 2005; 5:3226-3245
44. Miike K, Aoki M, Yamashita R, et al. Proteome profiling reveals gender differences in the composition of human serum. Proteomics 2010; 10:2678-2691
45. Fang X, Balgley BM, Lee CS: Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery. Electrophoresis 2009; 30:3998-4007
46. Huttenhain R, Malmstrom J, Picotti P, et al. Perspectives of targeted mass spectrometry for protein biomarker verification. Curr Opin Chem Biol 2009; 13:518-525
47. Paczesny S, Levine JE, Braun TM, et al. Plasma biomarkers in graft-versus-host disease: a new era? Biol Blood Marrow Transplant 2009; 15:33-38
48. Jacobs JM, Adkins JN, Qian WJ, et al. Utilizing human blood plasma for proteomic biomarker discovery. J Proteome Res 2005; 4:1073-1085
49. Lee DH, Kim JW, Jeon SY, et al. Proteomic analysis of the effect of storage temperature on human serum. Ann Clin Lab Sci 2010; 40:61-70
50. Thiele T, Steil L, Volker U, et al. Proteomics of blood-based therapeutics: a promising tool for quality assurance in transfusion medicine. BioDrugs 2007; 21:179-193
51. Power KA, McRedmond JP, de Stefani A, et al. High-throughput proteomics detection of novel splice isoforms in human platelets. PLoS One 2009; 4:e5001
52. Cagney G, McRedmond J: A central resource for platelet proteomics. Arterioscler Thromb Vasc Biol 2008; 28:1214-1215
53. Dittrich M, Birschmann I, Mietner S, et al. Platelet protein interactions: map, signaling components, and phosphorylation groundstate. Arterioscler Thromb Vasc Biol 2008; 28:1326-1331
54. Zahedi RP, Begonja AJ, Gambaryan S, et al. Phosphoproteomics of human platelets: a quest for novel activation pathways. Biochim Biophys Acta 2006; 1764:1963-1976
55. O'Neill EE, Brock CJ, von Kriegsheim AF, et al. Towards complete analysis of the platelet proteome. Proteomics 2002; 2:288-305
56. Qureshi AH, Chaoji V, Maiguel D, et al. Proteomic and phospho-proteomic profile of human platelets in basal, resting state: insights into integrin signaling. PLoS One 2009; 4:e7627
57. Dean WL, Lee MJ, Cummins TD, et al. Proteomic and functional characterisation of platelet microparticle size classes. Thromb Haemost 2009; 102:711-718
58. Klement GL, Yip TT, Cassiola F, et al. Platelets actively sequester angiogenesis regulators. Blood 2009; 113:2835-2842
59. Maynard DM, Heijnen HF, Horne MK, et al. Proteomic analysis of platelet alpha-granules using mass spectrometry. J Thromb Haemost 2007; 5:1945-1955
60. Kulkarni S, Kannan M, Atreya CD: Omic approaches to quality biomarkers for stored platelets: are we there yet? Transfus Med Rev 2010; 24:211-217
61. Schubert P, Devine DV: Towards targeting platelet storage lesion-related signaling pathways. Blood Transfus 2010; 8(Suppl 3):s69-s72
62. Springer DL, Miller JH, Spinelli SL, et al. Platelet proteome changes associated with diabetes and during platelet storage for transfusion. J Proteome Res 2009; 8:2261-2272
63. Glenister KM, Payne KA, Sparrow RL: Proteomic analysis of supernatant from pooled buffy-coat platelet concentrates throughout 7-day storage. Transfusion 2008; 48:99-107
64. Alexandre BM: Proteomic mining of the red blood cell: focus on the membrane proteome. Expert Rev Proteomics 2010; 7:165-168
65. D'Alessandro A, Righetti PG, Zolla L: The red blood cell proteome and interactome: an update. J Proteome Res 2010; 9:144-163
66. Roux-Dalvai F, Gonzalez de Peredo A, Simo C, et al. Extensive analysis of the cytoplasmic proteome of human erythrocytes using the peptide ligand library technology and advanced mass spectrometry. Mol Cell Proteomics 2008; 7:2254-2269
67. Zhang Y, Adachi J, Olsen JV, et al. MAPU: Max-Planck Unified database of organellar, cellular, tissue and body fluid proteomes. Nucleic Acids Res 2007; 35:D771-D779
68. Pasini EM, Kirkegaard M, Mortensen P, et al. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 2006; 108:791-801
69. Grazzini G: Transfusion medicine and proteomics: an alliance for blood quality and safety. Blood Transfus 2010; 8(Suppl 3):s6-s8
70. D'Alessandro A, Zolla L: Proteomics for quality-control processes in transfusion medicine. Anal Bioanal Chem 2010; 398:111-124
71. Liumbruno G, D'Alessandro A, Grazzini G, et al. How has proteomics informed transfusion biology so far? Crit Rev Oncol Hematol 2010; Jan 28 [Epub ahead of print] doi.
72. Schubert P, Devine DV: Proteomics meets blood banking: identification of protein targets for the improvement of platelet quality. J Proteomics 2009; 73:436-444